Nashville, TN, United States of America

David Charles

This inventor holds 2 USPTO granted patents. Top assignees: Vanderbilt University, Michigan State University. Active years: 2022-2023.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by David Charles in Parkinson's Disease Treatment

Introduction

David Charles is an accomplished inventor based in Nashville, TN (US), known for his significant contributions to the field of neurology, particularly in the treatment of Parkinson's Disease. With a total of 2 patents, he has focused on developing innovative methods to enhance the quality of life for patients suffering from this debilitating condition.

Latest Patents

One of his latest patents is titled "Deep brain stimulation in early stage Parkinson's." This patent discusses the treatment of patients with Parkinson's Disease using subthalamic nucleus deep brain stimulation targeted at a specific region of the brain. By positioning the electrode in the margin of the dorsal-lateral and anterior region of the subthalamic nucleus, improved therapeutic benefits are achieved. Another notable patent is "Predicting therapeutic response in Parkinson's disease," which provides methods and compositions for determining the susceptibility of Parkinson's disease patients to optimized drug therapy (ODT) and deep brain stimulation (DBS) therapy.

Career Highlights

David Charles has had a distinguished career, working with prestigious institutions such as Vanderbilt University and Michigan State University. His work has been instrumental in advancing the understanding and treatment of Parkinson's Disease, making a lasting impact in the field of neurology.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Mallory Hacker and Peter E Konrad. These collaborations have further enriched his research and innovations in the treatment of Parkinson's Disease.

Conclusion

David Charles continues to be a pivotal figure in the realm of neurological research, with his patents reflecting a commitment to improving patient outcomes in Parkinson's Disease. His innovative approaches and collaborations highlight the importance of ongoing research in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…